-
Sun Pharma Partners ICGEB to Develop Safer, Cheaper Dengue Vaccine
Drugmaker Sun PharmaBSE 0.01 % has partnered with International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a dengue vaccine which, it said, would be safer, effective and more affordable than the existing vaccine and other candidates being developed.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
Philips Showcases Low Cost New Innovations for Accurate Diagnosis, Treatment
As part of efforts to boost Nigeria’s healthcare standards, Philips West Africa, a medical and lifestyle equipment company has introduced a portfolio of data driven oncology, radiology and women’s health technology solutions across the health continuum in the country.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
-
Merck Merges Pharma, Consumer Health Units; Aims to Ramp Up Businesses
German drug maker MerckBSE 5.34 % has merged its pharmaceuticals and consumer healthcare businesses as part of a major makeover unique to India aimed at building scale and ramping up local business with a hybrid model.
- Categories
- Health Care
- Region
- South Asia
-
Ghana: Social Enterprise Impacts Thousands in Ghana
A new research by the Social Enterprise Activity in Ghana has revealed that 98 social enterprises in Ghana currently employ 998 young people directly, impacting 103,148 lives in Ghana.
- Categories
- Impact Assessment
- Region
- Sub-Saharan Africa
-
How Does India Fare in Access to Banking?
Financial inclusion may have become a buzzword among India’s econocrats and central bankers but India continues to lag behind most major economies when it comes to access to banking, the results of the Financial Access Survey for 2016 released by the International Monetary Fund (IMF) shows.
- Categories
- Uncategorized
- Region
- South Asia
-
Research: A Sustainable Model for Delivering High-Quality, Efficient Cataract Surgery in Southern India
Cataracts are a leading cause of reversible blindness in India, where millions of people can be effectively treated for this condition with surgery. The Aravind Eye Care System in southern India developed an efficient system for delivering high-quality and low-cost cataract surgery. We provide a detailed accounting of costs of cataract surgery at the system and a cost-utility analysis. Total costs per operation were US$120, or $195 per quality-adjusted life-year gained. Using these data and population-based estimates of cataract prevalence, we calculate that eliminating cataract-related blindness and low vision in India would cost $2.6 billion and would yield a net societal benefit of $13.5 billion. Factors contributing to the highly cost-effective care at the Aravind Eye Care System include the domestic manufacturing of supplies, the use of a specialized workforce and standardized protocols, and the presence of few regulatory hurdles. Lessons learned from the system can help improve the delivery of cataract surgery and other ambulatory care surgeries in India and abroad.
- Categories
- Health Care
- Region
- South Asia
-
WHO Seeks New Mechanism for Crisis Vaccine Supplies At Low Cost
The World Health Organization, drugmakers and humanitarian groups are hammering out details of a new vaccine supply system aimed at getting vital shots to vulnerable people in crises such as wars or natural disasters.
- Categories
- Health Care
- Tags
- vaccines
-
UNICEF: Vaccine Price Drop Will Save Millions of Child Lives
The U.N. Children’s Fund reports a steep drop in the price of a crucial childhood vaccine will prevent millions of deaths in dozens of the world’s poorest countries.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.